Risk Factors Update Summary
- Accumulated deficit increased from $108 million to $629 million, indicating significant financial challenges.
- Net losses rose from $11,394,170 to $14,247,124, showing a negative trend in profitability.
- Sales and marketing capabilities expansion required for FemaSeed commercialization, indicating increased costs and efforts.
- Increase in issued U.S. patents from 48 to 32, highlighting enhanced intellectual property protection.
- Full-time employees decreased from 34 to 32, potentially impacting operational capacity.
- Pending foreign patent applications rose from 17 to 25, indicating a focus on global protection.
- Increased consultants from 18 to 21, suggesting a reliance on external expertise for operations.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1339005&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.